UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - colon+carcinoma
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Antitumor activity of NKTR-214 alone or in combination with anti-PD-1 therapy in tumors resistant to anti-PD-1 (UCLA Case No. 2019-254)
UCLA researchers have discovered a therapy for anti-PD-1 resistant tumors in
colon carcinoma
patients. A small molecule therapeutic alone or in combination with immune-checkpoint blockade (ICB) therapy exhibits tumor remission even in sublines with mutated signalling pathways that have rendered them ICB resistant. BACKGROUND: Immunotherapy, the...
Published: 2/15/2024
|
Inventor(s):
Antoni Ribas
Keywords(s):
Colon carcinoma
,
Immune checkpoint blockade
,
Immunotherapy
,
Oncology
,
Oncology (Small Molecules, Peptides and Antibodies)
,
PD-1
,
PD-L1
,
Resistant tumors
,
Signaling pathways
,
Small molecule therapeutics
,
Tumor
Category(s):
Life Science Research Tools
,
Therapeutics > Oncology > Oncology Immunotherapy
,
Therapeutics > Oncology > Oncology (Small Molecules)